Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Axsome Therapeutics, Inc. | General Counsel | Restricted Stock Units | 13K | $974K | $75.18 | Feb 27, 2024 | Direct |
Axsome Therapeutics, Inc. | General Counsel | Employee Stock Option (Right to Buy) | 23.6K | Feb 27, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AXSM | Axsome Therapeutics, Inc. | Feb 27, 2024 | 2 | $0 | 4 | Feb 29, 2024 | General Counsel |
AXSM | Axsome Therapeutics, Inc. | Mar 2, 2023 | 2 | $0 | 4 | Mar 6, 2023 | General Counsel |
AXSM | Axsome Therapeutics, Inc. | Jun 13, 2022 | 0 | $0 | 3 | Jun 15, 2022 | General Counsel |